MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

The Oncology Institute, Inc. - Warrant (NQ:TOIIW)

0.0490 UNCHANGED
Last Price Updated: 3:30 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0490
Bid (Size) 0.0351 (2,000)
Ask (Size) 0.0597 (900)
Prev. Close 0.0490
Today's Range 0.0490 - 0.0490
52wk Range 0.0250 - 0.2725
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Starling Oncology to Participate in Wells Fargo Healthcare Conference
From Starling Oncology
Via GlobeNewswire
News headline image
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
Company’s proprietary platform brings clinical decision support and evidence-based pathways into one streamlined oncology workflow 
From Starling Oncology
Via GlobeNewswire

Performance

YTD
-62.3%
-62.3%
1 Month
N/A
N/A
3 Month
-10.1%
-10.1%
6 Month
-4.3%
-4.3%
1 Year
-62.3%
-62.3%

More News

Read More
News headline image
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
From Starling Oncology
Via GlobeNewswire
News headline image
The Oncology Institute Rebrands as Starling Oncology
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Reports First Quarter 2026 Financial Results
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Achieves $1.8 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 3, Marking Significant Period-Over-Period Improvement
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute to Participate in the 25th Annual Needham Healthcare Conference
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Names Minh Merchant Chief Legal Officer
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Appoints Kim Tzoumakas to Board of Directors
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Announces Leadership Promotions
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Announces Addition of Board Member Mark Stolper
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Announces Resignation of Board Member Gabe Ling
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
From TOI Management, LLC
Via GlobeNewswire
News headline image
Ascertain and The Oncology Institute Co-Develop ‘Touchless’ AI Automation for Oncology Administration
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call
From TOI Management, LLC
Via GlobeNewswire
News headline image
The Oncology Institute to Participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference
From TOI Management, LLC
Via GlobeNewswire

Frequently Asked Questions

Is The Oncology Institute, Inc. - Warrant publicly traded?
Yes, The Oncology Institute, Inc. - Warrant is publicly traded.
What exchange does The Oncology Institute, Inc. - Warrant trade on?
The Oncology Institute, Inc. - Warrant trades on the Nasdaq Stock Market
What is the ticker symbol for The Oncology Institute, Inc. - Warrant?
The ticker symbol for The Oncology Institute, Inc. - Warrant is TOIIW on the Nasdaq Stock Market
What is the current price of The Oncology Institute, Inc. - Warrant?
The current price of The Oncology Institute, Inc. - Warrant is 0.0490
When was The Oncology Institute, Inc. - Warrant last traded?
The last trade of The Oncology Institute, Inc. - Warrant was at 07/31/26 03:30 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story